Local Institution

Windsor, Ontario N9A 1C9

0 studies enrolling now · 12 studies all time

What they study most

Acute Coronary Syndrome, Advanced Cutaneous Melanoma, Deep Vein Thrombosis, Hypertension, Non-Small-Cell Lung Carcinoma, Psoriasis, Pulmonary Embolism, Type 2 Diabetes Mellitus, Venous Thrombosis

Studies at this site

• A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma — Completed
• Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery — Completed
• Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness — Completed
• Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer — Completed
• Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3) — Completed
• Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed
• Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension — Completed
• Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes — Completed
• BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery — Completed